Novartis Given Reprieve In Elidel FCA Suit

Law360, New York (October 26, 2012, 7:46 PM EDT) -- A Pennsylvania federal judge on Friday dismissed a former Novartis Pharmaceuticals Corp. employee’s False Claims Act suit accusing the company of off-label marketing and kickbacks related to eczema treatment Elidel, but gave the former employee leave to amend his complaint.

Granting Novartis’ motion to dismiss, U.S District Judge Gene E.K. Pratter said relator Donald R. Galmines, a former Novartis senior sales consultant, had failed to sufficiently prove he had voluntarily provided information on his allegations to the federal government before filing his qui tam suit as...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.